Jatter,
I'll still back myself. You lot said the same about the investment experts and analysts and the ex-sirtex management! And who was right?
So I'll stick to my guns and point out to you that the CE marking process is dead... and the IDE was rejected. Rather than rejoicing about another dead wood appointment, why not ask Daniel to release the FDA response to the IDE application?
End of February now? pffft not a hope in hell! Can they get approval ever? OSL hasn't even done the basic groundwork to even start a clinical trial!
Regards,
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
-0.070(5.69%) |
Mkt cap ! $16.49M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.25 | $1.11 | $72.36K | 60.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9286 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.18 | 412 | 1 |
View Market Depth
| Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |